Ownership history in Bleichroeder LP · 11 quarters on record
This page tracks every 13F SEC filing in which Bleichroeder LP reported a position in DIAMEDICA THERAPEUTICS INC (DMAC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 382,317 | — | 0% | 0.54% | $3.0M | $7.96 |
| 2025 Q3 | UNCHANGED | 382,317 | — | 0% | 0.51% | $2.6M | $6.87 |
| 2025 Q2 | UNCHANGED | 382,317 | — | 0% | 0.37% | $1.5M | $3.90 |
| 2025 Q1 | UNCHANGED | 382,317 | — | 0% | 0.39% | $1.4M | $3.79 |
| 2024 Q4 | UNCHANGED | 382,317 | — | 0% | 0.52% | $2.1M | $5.43 |
| 2024 Q3 | UNCHANGED | 382,317 | — | 0% | 0.43% | $1.6M | $4.19 |
| 2024 Q2 | ADDED | 382,317 | +160,000 | +72.0% | 0.34% | $1.1M | $2.95 |
| 2024 Q1 | UNCHANGED | 222,317 | — | 0% | 0.15% | $616K | $2.77 |
| 2023 Q4 | UNCHANGED | 222,317 | — | 0% | 0.14% | $631K | $2.84 |
| 2023 Q3 | REDUCED | 222,317 | -71,800 | -24.4% | 0.14% | $574K | $2.58 |
As of 2025 Q4 — sorted by position size